Insider · CIK 0001291937

Bertrand William C JR

Reports to the SEC for 6 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001291937

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+12.3K sh	—	—	303,052
2026-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,715
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+26.5K sh	—	—	329,507
2025-08-28	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−207K sh	$0.01	−$2,090.7	986,352
2025-06-18	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+54.1K sh	—	—	54,059
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+19.4K sh	—	—	249,156
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+41.6K sh	—	—	290,707
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+1.61M sh	—	—	1,612,032
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+1.07M sh	—	—	1,074,696
2025-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−5,584 sh	$0.58	−$3,243.187	7,510
2025-01-15	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−9,803 sh	$0.57	−$5,634.764	13,756
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,268 sh	$0.59	−$2,509.157	5,845
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−5,471 sh	$0.59	−$3,216.401	7,623
2024-06-14	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,243
2024-06-14	ARDXARDELYX, INC.A Award	Director	AAward	+11K sh	—	—	229,766
2024-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−13.6K sh	$0.67	−$9,152.127	20,201
2024-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−5,309 sh	$0.67	−$3,572.957	7,785
2024-01-16	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,681 sh	$0.79	−$3,697.99	7,023
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+565K sh	—	—	565,416
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+2.54M sh	—	—	2,544,432
2024-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−5,220 sh	$0.85	−$4,458.402	7,874
2024-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,009 sh	$0.84	−$3,354.33	6,104
2023-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,237
2023-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+16.6K sh	—	—	218,743
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+1.41M sh	—	—	1,407,072
2023-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,440 sh	$1.86	−$8,249.52	7,264
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+203K sh	—	—	202,800
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+314K sh	—	—	314,256
2023-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,973 sh	$1.71	−$8,483.938	8,121
2023-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−3,843 sh	$1.75	−$6,712.952	6,270
2023-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−3,584 sh	$1.69	−$6,071.296	5,781
2022-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+119K sh	—	—	202,162
2022-01-18	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,368 sh	$3.19	−$13.9K	7,336
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+314K sh	—	—	314,256
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+1.41M sh	—	—	1,407,072
2022-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−2,248 sh	$3.54	−$7,967.137	3,754
2022-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−3,770 sh	$3.56	−$13.4K	6,343
2022-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−3,490 sh	$4.06	−$14.2K	5,873
2021-07-02	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−4,375 sh	$4.26	−$18.7K	7,329
2021-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+8,891 sh	—	—	83,549
2021-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+32.8K sh	—	—	32,765
2021-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−2,234 sh	$6.15	−$13.7K	3,768
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+1.09M sh	—	—	1,086,816
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Operating Officer	AAward	+243K sh	—	—	242,712
2021-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Operating Officer	SSale	−3,499 sh	$5.33	−$18.6K	5,864
2020-12-14	ADAPAdaptimmune Therapeutics PLCP Purchase	Chief Operating Officer	PPurchase	+207K sh	$0.69	+$144K	284,808
2020-12-14	ARDXARDELYX, INC.A Award	Director	AAward	+15K sh	$7.08	+$106K	74,658
2020-06-09	ARDXARDELYX, INC.A Award	Director	AAward	+7,523 sh	—	—	59,658
2020-06-09	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500

Recent filings

Accepted (ET)
Jun 184
Bertrand William C JR0001291937-26-000003
SEC(opens sec.gov)
Aug 294
Bertrand William C JR0001104659-25-085820
SEC(opens sec.gov)
Jun 234
Bertrand William C JR0001628280-25-032724
SEC(opens sec.gov)
Feb 204
Bertrand William C JR0001104659-25-015746
SEC(opens sec.gov)
Jan 174
Bertrand William C JR0001104659-25-004606
SEC(opens sec.gov)
Jan 154
Bertrand William C JR0001104659-25-003765
SEC(opens sec.gov)
Jun 174
Bertrand William C JR0001628280-24-028600
SEC(opens sec.gov)
Jan 174
Bertrand William C JR0001104659-24-004560
SEC(opens sec.gov)
Jan 174
Bertrand William C JR0001104659-24-004531
SEC(opens sec.gov)

Companies

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451